Correction to: protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases

被引：0
|
作者：
Dorothea M. Heuberger
Reto A. Schuepbach
机构：
[1] University Hospital Zurich,Institute of Intensive Care Medicine
[2] University of Zurich,Surgical Research Division
[3] University Hospital Zurich,undefined
[4] University of Zurich,undefined
来源：
Thrombosis Journal | / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Following the publication of this article [1], the authors reported an incorrect citation in the following sentence in the “Metalloproteases” sub-section:
引用
收藏
相关论文
共 28 条
  • [1] Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
    Heuberger, Dorothea M.
    Schuepbach, Reto A.
    THROMBOSIS JOURNAL, 2019, 17 (1)
  • [2] Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
    Dorothea M. Heuberger
    Reto A. Schuepbach
    Thrombosis Journal, 17
  • [3] protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases (vol 17, 4, 2019)
    Heuberger, Dorothea M.
    Schuepbach, Reto A.
    THROMBOSIS JOURNAL, 2019, 17 (01)
  • [4] Protease-Activated Receptors (PARs): Biology and Therapeutic Potential in Perioperative Stroke
    Mavridis, Theodoros
    Choratta, Theodora
    Papadopoulou, Androniki
    Sawafta, Assaf
    Archontakis-Barakakis, Paraschos
    Laou, Eleni
    Sakellakis, Minas
    Chalkias, Athanasios
    TRANSLATIONAL STROKE RESEARCH, 2024,
  • [5] Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases
    Posma, Jens J.
    Grover, Steven P.
    Hisada, Yohei
    Owens, A. Phillip, III
    Antoniak, Silvio
    Spronk, Henri M.
    Mackman, Nigel
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39 (01) : 13 - 24
  • [6] Development of agonists/antagonists for protease-activated receptors (PARs) and the possible therapeutic application to gastrointestinal diseases
    Sekiguchi, F
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 (06): : 491 - 498
  • [7] Expression of protease-activated receptors (PARs) and PAR-induced calcium signaling in oligodendrocytes
    Wang, YF
    Richter-Landsberg, C
    Reiser, G
    GLIA, 2003, : 57 - 57
  • [8] Protease-Activated Receptors - Key Regulators of Inflammatory Bowel Diseases Progression
    Jacenik, Damian
    Fichna, Jakub
    Malecka-Wojciesko, Ewa
    Mokrowiecka, Anna
    JOURNAL OF INFLAMMATION RESEARCH, 2021, 14 : 7487 - 7497
  • [9] Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome?
    Gloro, R
    Ducrotte, P
    Reimund, JM
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (05) : 1079 - 1095
  • [10] Physiology, pharmacology, and therapeutic potential of protease-activated receptors in vascular disease
    Lee, Hannah
    Hamilton, Justin R.
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (02) : 246 - 259
123